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Introduction
Antibiotic stewardship has been defined as coordinated 
interventions designed to improve and measure the appropriate 
use of antibiotic agents. This is accomplished by promoting 
the selection of the optimal antibiotic drug regimen including 
dosing, duration of therapy, and route of administration [1]. 
Successful implementation of antimicrobial stewardship 
programs has been associated with several benefits. These 
include improved patient outcomes, reduced adverse events 
including Clostridium difficile infection (CDI), decreased 
antibiotic resistance, and resource optimization such as 
decreased length of stay and cost of care. As a result of this, The 
Joint Commission, a United States not-for-profit organization 
dedicated to improving quality and effectiveness in healthcare, 
now requires an antimicrobial stewardship program (ASP) for 
hospital accreditation and certification. Additionally, in 2016, 
The Infectious Disease Society of America (IDSA) released 
national guidelines on implementing an ASP [2].
Respiratory infections are the most common infectious reason 
for hospitalization in the United States [3]. Therefore, one could 
extrapolate that respiratory infections are then also the most 
common reason for hospital antibiotic use and possess the 
highest potential for hospital antibiotic misuse. To address this 
concern, as well as antibiotic misuse as a whole, a program to 
improve antibiotic use was created at the Robley Rex Louisville 
VA Medical Center (VAMC) in 1990 [4]. The antimicrobial 
stewardship team (AST) was formed as part of the ASP, and 
members included infectious diseases pharmacists, infectious 
disease physicians, and a microbiologist. Hospital guidelines for 
the management of different infections were created by the AST 
and monthly reports were generated detailing hospital antibiotic 
use. In general, hospital guidelines reflect the implementation 
of national guidelines at the local level. Antibiotic use was 
determined to be either complaint or non-compliant with 
hospital guidelines. If antibiotic use was found to be compliant 
with hospital guidelines, no antibiotic recommendations were 
made. If antibiotic use was determined to be non-complaint with 
hospital guidelines, recommendations were made by the AST in 
the medical record. In the instances where recommendations 
were made, we then tracked if the recommendations were 
accepted or not accepted. To generate these reports a program 
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was developed in Microsoft Access and entitled Switch Therapy 
and Antimicrobial Review [5].
The primary objective of this article was to evaluate the role 
of antimicrobial stewardship on improving antibiotic use for 
respiratory infections in hospitalized patients on intravenous 
(IV) antibiotics at the Robley Rex Louisville VAMC over a 10-
year period. The secondary objectives included describing the 
most common 1) types of infections, 2) pathogens associated 
with respiratory infections, and 3) IV antibiotics used for 
respiratory infections with respective compliance with hospital 
guidelines before and after recommendations over the same 10-
year period.
Materials and Methods
This was a retrospective review of the Robley Rex Louisville 
VAMC ASP Switch Therapy and Antimicrobial Review database. 
The study included all Robley Rex Louisville VAMC patients 
admitted to the hospital and placed on IV antibiotics between 
January 1st 2007 and December 31st 2016. This study was 
approved by the Robley Rex Louisville VAMC and informed 
consent was waived (IRB ID: 00049 Prom#: 0061). Data on 
each patient was collected by the antimicrobial stewardship 
pharmacist after they were alerted that the patient was 
receiving IV antibiotic treatment. The data collection included 
the following 15 variables; patient age, gender, admit date, 
discharge date, onset date and where infection was acquired, 
diagnosis, antibiotic name as well as antibiotic start and 
stop date, antibiotic indication and dose, culture results, and 
annotation indicating if antibiotic therapy was pathogen-
directed or empiric and whether or not a patient was a candidate 
for oral switch therapy. This information was then used to 
evaluate antibiotic use.
The AST pharmacist gave real time feedback on intravenous 
antimicrobial orders and evaluated the compliance with local 
hospital antimicrobial guidelines. Areas of compliance that were 
reviewed consisted of the following; evaluation of the initial 
empiric regimen for appropriateness of spectrum of coverage, 
appropriateness of dose based on diagnosis, and potential 
for use of a less toxic antimicrobial agent. Continued review 
occurred throughout the patient’s hospitalization following the 
initial evaluation and was based on clinical response and culture 
results with an evaluation of length of therapy and possibility 
for de-escalation of the empiric regimen. Prospective audit 
and feedback occurred with recommendations from the AST 
documented in the patient electronic record and in some cases 
through additional phone call or face to face discussion with the 
prescriber.
Study Definitions
Respiratory infections in this study were classified at the time 
of diagnosis in the database as either community-acquired 
pneumonia (CAP), healthcare-associated pneumonia (HCAP), 
hospital-acquired pneumonia (HAP), ventilator-associated 
pneumonia (VAP), acute exacerbation of chronic obstructive 
pulmonary disease (AECOPD), empyema, or lung abscess. 
The type of respiratory infection was defined by the primary 
physician’s diagnosis as documented in the patient’s record.
Infectious cases were defined as an infection requiring IV 
antibiotics upon or during a hospital admission. Each inpatient 
infection requiring IV antibiotics represented a case.
Antibiotic courses were defined by each individual IV antibiotic 
regimen a patient received during a particular infectious case. 
A single infectious case may have received numerous antibiotic 
courses.
The following 4 criteria were used to define when a patient 
should be considered a candidate for oral switch therapy: 
[1] cough and shortness of breath improving, [2] afebrile 
(temperature, <37.8°C) for at least 8 hours, [3] white blood 
cell count normalizing, and [4] adequate oral intake and 
gastrointestinal tract absorption. A patient who was able to take 
food by mouth without evidence of diarrhea or malnutrition was 
considered to have adequate oral intake and gastrointestinal 
tract absorption.
Antibiotic compliance was assessed daily during admission 
regarding appropriateness of empiric or pathogen directed 
therapy, dosing, and duration.
Statistical Analysis
Descriptive statistics were performed. Data was reported as 
frequencies (n) and percentages (%). The percent compliance 
before and after AST recommendation was calculated by 
dividing the total number of compliant evaluations and the total 
number of compliant opportunities. Line graphs were produced 
to display changes in compliance over time. Statistical analysis 
was performed with R version 3.3.2 [6].
Results
Antibiotic compliance with hospital guidelines before and after 
the AST recommendations are demonstrated by year for the 
most prominent respiratory infections including CAP, HCAP, 
HAP, as well as all respiratory infections combined in Figures 
1-4.
Fig. 1. Antibiotic compliance with hospital guidelines for community-
acquired pneumonia before and after antimicrobial stewardship team 
(AST) recommendations.
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Fig. 2. Antibiotic compliance with hospital guidelines for healthcare-
associated pneumonia before and after antimicrobial stewardship team 
(AST) recommendations.
Fig. 3. Antibiotic compliance with hospital guidelines for hospital-
acquired pneumonia before and after antimicrobial stewardship team 
(AST) recommendations.
Fig. 4. Antibiotic compliance with hospital guidelines for all respiratory 
infections before and after antimicrobial stewardship team (AST) 
recommendations.
A total of 18,932 IV antibiotic courses were reviewed by the 
AST at the Robley Rex Louisville VAMC during the 10-year 
time period. This was representative of 5,928 infectous cases. 
Respiratory infections accounted for 6,882IV antibiotic courses 
used in 2,133 infectious. The total of IV antibiotic courses and 
infectious cases reviewed by the AST for respiratory infections 
are listed by infection type in Table 1.
Table 1. Respiratory Infections and Antibiotic Courses
CAP: community-acquired pneumonia; HCAP: healthcare-associated pneumonia; HAP: hospital-
acquired pneumonia; AECOPD: acute exacerbation of chronic obstructive pulmonary disease; VAP: 
ventilator-associated pneumonia
The complete list of IV antibiotic courses and infectious cases 
reviewed by the AST for all other types of infections are listed by 
infection type in Table 2.
Table 2. Other Infections and Antibiotic Courses
The most common respiratory pathogens identified in our 
hospital are listed in Table 3.
Table 3. Most Frequent Organisms by Type of Pneumonia
†MSSA: methicillin-susceptible Staphylococcus aureus; ‡MRSA: methicillin-resistant Staphylococcus 
aureus
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Diagnosis Infections (n=2,133) Antibiotic Courses (n=6,882) 
CAP 
HCAP 
HAP 
AECOPD 
Empyema 
VAP 
Lung Abscess 
778 (36) 
580 (27) 
465 (22) 
186 (9) 
69 (3) 
50 (2) 
5 (0) 
2143 (31) 
2092 (30) 
1771 (26) 
280 (4) 
374 (5) 
208 (3) 
14 (0) 
Diagnosis Infections Antibiotic Courses 
Bone and Joint Infections 517 (14) 2475 (21) 
Osteomyelitis 453 (88) 2285 (92) 
Septic Joint 64 (12) 190 (8) 
Central Nervous System Infections 63 (2) 189 (2) 
Meningitis 
Encephalitis 
Syphilis 
Brain Abscess 
Ventriculoperitoneal Shunt Infection 
50 (79) 
9 (14) 
2 (3) 
1 (2) 
1 (2) 
151 (80) 
26 (14) 
2 (1) 
4 (2) 
6 (3) 
Endovascular Infections 293 (8) 1213 (10) 
Intravenous Catheter Infection 
Endocarditis 
Vascular graft 
153 (52) 
108 (37) 
32 (11) 
585 (48) 
428 (35) 
200 (16) 
Intra-abdominal Infections 508 (13) 1393 (12) 
Peritonitis 
Cholecystitis 
Intra-abdominal Abscess 
C. difficile Colitis 
Diverticulitis 
Pancreatitis 
148 (29) 
116 (23) 
97 (19) 
89 (18) 
38 (7) 
20 (4) 
478 (34) 
253 (18) 
375 (27) 
138 (10) 
93 (7) 
56 (4) 
Skin and Soft Tissue Infections 706 (19) 2238 (19) 
Cellulitis 
Surgical Wound Infection 
Diabetic Foot Infection 
540 (76) 
72 (10) 
54 (8) 
1587 (71) 
236 (11) 
223 (10) 
Perirectal Abscess 
Necrotizing fasciitis 
Myonecrosis 
24 (3) 
13 (2) 
3 (0) 
55 (2) 
118 (5) 
19 (1) 
Urinary Tract Infections 971 (26) 2209 (18) 
Pyelonephritis 
Cystitis 
713 (73) 
258 (27) 
1853 (84) 
356 (16) 
Other Infections  737 (19) 2333 (19) 
CAP n (%) HAP n (%) HCAP n (%) 
S. pneumonia 
H. influenzae 
MSSA 
MRSA 
Pseudomonas 
Streptococcus other 
Klebsiella 
E. coli 
Moraxella 
73 (27) 
32 (12) 
31 (11) 
24 (9) 
18 (7) 
16 (6) 
13 (5) 
9 (3) 
6 (2) 
MRSA† 
Pseudomonas 
Klebsiella 
Enterobacter 
E. coli 
MSSA‡ 
H. influenzae 
S. pneumoniae 
Acinetobacter 
85 (28) 
40 (13) 
33 (11) 
21 (7) 
18 (6) 
18 (6) 
15 (5) 
10 (3) 
6 (2) 
MRSA† 
Pseudomonas 
MSSA‡ 
S. pneumoniae 
E. coli 
H. influenzae 
Proteus 
Klebsiella 
Enterobacter 
77 (27) 
45 (16) 
33 (11) 
25 (9) 
24 (8) 
13 (4) 
12 (4) 
11 (4) 
8 (3) 
The most frequently used IV antibiotics for respiratory infections 
in our hospital as well as compliance with hospital guidelines 
before and after recommendations are listed in Table 4.
Table 4. Most frequently used antibiotics for respiratory infections with 
respective compliance with hospital guidelines.
†Percent compliance
Reasons for non-compliance by our evaluation included 
inappropriate empiric or pathogen directed antimicrobial 
therapy regarding agent, dose, duration, or toxicity.
Discussion
The results of this study demonstrate that recommendations 
from an AST regarding antibiotic use for respiratory infections 
improve compliance with hospital guidelines. This is consistent 
with other studies that have demonstrated improvement in 
antibiotic use after intervention from an ASP for other types of 
infection such as skin and soft tissue infections [7,8]. However, 
while our study demonstrated improved compliance with 
hospital guidelines after AST recommendations each year, the 
data did not demonstrate an overall improvement in antibiotic 
use before recommendations over time as one may expect with 
continuous audit and feedback. This is can be explained by the 
fact that our institution is a teaching hospital. Residents rotate 
through regulary providing an essentially continual influx of 
new learners.
Lack of improvement in antibiotic use over time prior to 
guideline based recommendations, highlights the importance 
of and role for an ongoing antimicrobial stewardship presence. 
This suggests that not only developing guidelines but forming 
and supporting an AST to assist with implementation of the 
guidelines on a local level is essential. Local implemenation 
of national guidelines is an area that has been shown to need 
improvement [9]. Our study suggests that an AST may help to 
bridge that gap.
Going forward, in the absence of uniform national guidelines, 
the creation of locally based hospital guidelines for a particular 
infection type via an ASP may further promote appropriate 
antibiotic use where it would otherwise be lacking. For example, 
at the Robley Rex Louisville VAMC we are developing local 
guidelines for hospitalized patients with COPD exacerbations, a 
common reason for hospitalization for which national guidelines 
are not yet established.
Lastly, our study reinforced that respiratory infections are 
a common reason for hospitalization and administration of 
IV antibiotics. In fact, our results demonstrated that overall, 
respiratory infections were the most common reason for 
hospitalization requiring IV antibiotics at the Robley Rex 
Louisville VAMC.  As one might expect, the most common 
etiology for CAP was Streptococcus pneumoniae, and the 
most common pathogens causing healthcare-associated 
respiratory tract infections included MRSA and Pseudomonas 
aeruginosa. This exemplifies the reason for differing guideline 
recommendations regarding empiric therapy for respiratory 
infections depending on the type of infection and patient 
risk factors. Illustrating the effectiveness of antimicrobial 
stewarship, the most commonly used IV antibiotics for those 
infections in this study were appropriate.
This study had several limitations including that is was a 
retrospective review with no utcome data. Without outcome 
data it is impossible to say that improved antibiotic use was 
associated with improved patient outcomes. Also, because this 
study took place in a teaching hospital we cannot assume that 
the results are generalizable to all inpatient hospital settings. 
In conclusion, there is an ongoing role for ASP’s and antibiotic 
guidance over time as it does appear to improve antibiotic 
use. Following national trends, the most common reasons 
for hospitalization requiring IV antibiotics were respiratory-
associated infections.
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